Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Oligodendroglioma × gallium Ga 68 dotatate × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 3 Neuroblastoma 2 von Hippel-Lindau Disease 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Parathyroid Neoplasms 1 Paraganglioma 1 Multiple Endocrine Neoplasia 1 Medulloblastoma 1 Hypoglycemia 1 Hyperparathyroidism 1 Hypercalcemia 1 Carcinoid Tumor 1 Cancer Diagnosis 1

Interventions

Temozolomide 14 Bevacizumab 11 Erlotinib Hydrochloride 5 Radiotherapy 4 Carboplatin 4 Irinotecan 3 Immunoglobulin G 3 Disulfides 3 poly ICLC 2 palbociclib 2 etoposide phosphate 2 Vincristine 2 Sunitinib 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Dasatinib 2 veliparib 1 varlilumab 1 vandetanib 1 trebananib 1 trametinib 1 terameprocol 1 temsirolimus 1 tandutinib 1 selinexor 1 romidepsin 1 picropodophyllin 1 pemigatinib 1 niraparib 1 nintedanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡